Effect of frusemide administration on calcium excretion

Area of Science:

• Nephrology
• Endocrinology
• Metabolic Disorders

Background:

• Frusemide is a diuretic commonly used for fluid management.
• Hypercalciuria, elevated calcium in urine, can have various causes and consequences.
• The metabolic effects of diuretics in patients with obesity require further investigation.

Purpose of the Study:

• To investigate the effect of oral frusemide on urinary calcium excretion in patients with obesity on a reducing diet.
• To determine the duration of hypercalciuria induced by frusemide.
• To explore the relationship between sodium and calcium excretion during frusemide administration.

Main Methods:

• Eight patients with obesity on a reducing diet received daily oral frusemide for four days.
• Urinary calcium and sodium excretion rates were monitored daily.
• Statistical analysis was performed to assess significance and correlations.

Main Results:

• Significant hypercalciuria was observed during the first three days of frusemide administration.
• Urinary calcium excretion returned to normal levels by day four, despite continued frusemide treatment.
• A close correlation was found between the rates of urinary sodium and calcium excretion.

Conclusions:

• Short-term oral frusemide administration can induce transient hypercalciuria in patients with obesity on a reducing diet.
• The body may adapt to frusemide, normalizing calcium excretion over time.
• Sodium and calcium excretion are closely linked during diuretic therapy, suggesting shared regulatory mechanisms.